0001104659-23-130005.txt : 20240130 0001104659-23-130005.hdr.sgml : 20240130 20231228141308 ACCESSION NUMBER: 0001104659-23-130005 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Astria Therapeutics, Inc. CENTRAL INDEX KEY: 0001454789 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 75 STATE STREET STREET 2: SUITE 1400 CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 617-349-1971 MAIL ADDRESS: STREET 1: 75 STATE STREET STREET 2: SUITE 1400 CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: CATABASIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20090127 CORRESP 1 filename1.htm

ASTRIA THERAPEUTICS, INC.

75 State Street

Suite 1400

Boston, Massachusetts 02109

December 28, 2023

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Re:	Astria Therapeutics, Inc.
	Registration Statement on Form S-3
	File No. 333-276057
	Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Astria Therapeutics, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-276057), so that it may become effective at 4:30 p.m. Eastern time on December 29, 2023, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff.

	Very truly yours,

	ASTRIA THERAPEUTICS, INC.

	By:	/s/ Ben Harshbarger
	Name:	Ben Harshbarger
	Title:	Chief Legal Officer and Corporate Secretary

cc:	Rosemary G. Reilly, Esq.

Wilmer Cutler Pickering Hale and Dorr LLP